![](/img/cover-not-exists.png)
The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck
Adeberg, Sebastian, Akbaba, Sati, Lang, Kristin, Held, Thomas, Verma, Vivek, Nikoghosyan, Anna, Bernhardt, Denise, Münter, Marc, Freier, Kolja, Plinkert, Peter, Hauswald, Henrik, Herfarth, Klaus, RiekLanguage:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2019.09.036
Date:
October, 2019
File:
PDF, 407 KB
english, 2019